Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Work In Process (2021 - 2022)

Pulse Biosciences has reported Work In Process over the past 2 years, most recently at $1.8 million for Q2 2022.

  • Quarterly results put Work In Process at $1.8 million for Q2 2022, changed N/A from a year ago — trailing twelve months through Jun 2022 was $1.8 million (changed N/A YoY), and the annual figure for FY2021 was $1.4 million, changed.
  • Work In Process for Q2 2022 was $1.8 million at Pulse Biosciences, up from $1.7 million in the prior quarter.
  • Over the last five years, Work In Process for PLSE hit a ceiling of $1.8 million in Q2 2022 and a floor of $1.2 million in Q3 2021.